Bruker Expands Clinical Microbiology and Infection Diagnostics Portfolio
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Bruker enhanced diagnostic solutions in microbial identification, antimicrobial susceptibility testing, early sepsis diagnostics, and more.
Siemens Healthineers has contracted with the National Institutes of Health (NIH) to improve antibiotic treatment for sepsis patients.
A diagnostic tool that detects sepsis in patients in under 10 minutes is now in use at Our Lady of the Lake Regional Medical Center.
Cytovale, a medical diagnostics company focused on advancing early detection technologies, announced that its IntelliSep test has received U.S. Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis.
Read MoreAt the request of IIROC, Asep Medical Holdings clarified its disclosure regarding its diagnostic and therapeutic technologies.
Read MoreResearchers have developed a new diagnostic method that applies machine learning to advanced genomics data to identify and predict sepsis.
Read MoreT2 Biosystems is expanding the number of pathogens detected on its T2Bacteria Panel to include the detection of Acinetobacter baumannii.
Read MoreA simple test that can be a beacon for improved patient outcomes, shorter lengths-of-stays, and reduced rates of antibiotic prescription and antibiotic resistance1-6
Read MoreCytovale revealed its 510(k) pending Cytovale system and 10-minute IntelliSep sepsis risk stratification test at AAACC.
Read MorePatients are 20% less likely to die of sepsis when detected by a new AI system that catches symptoms hours earlier than traditional methods.
Read MoreImproving outcomes with sepsis is dependent on timely diagnosis and treatment. Culture-independent testing is one way to save time.
Read MoreA new test can predict sepsis before blood clots cause organ damage by detecting shifts in blood protein abundance soon after infection.
Read MorePrenosis, Inc.is expanding its existing partnership with Roche Diagnostics that will to improve and expedite the clinical recognition of sepsis.
Read MoreResearchers have developed a new tool that could help provide early warnings of potentially deadly bacterial pathogens which cause sepsis, among other uses.
Read MoreKe Du, PhD, is developing a microfluidic device to improve detection of drug resistant bacteria in blood, one of the most common pathogens causing sepsis.
Read MoreIn screening for sepsis in newborns, there is a need to develop sensitive, and integrated diagnostic strategies to enhance detection.
Read MoreMagnolia Medical Technologies, Inc., announces its new Steripath Micro Initial Specimen Diversion Device designed for children’s hospitals.
Read MoreNanoDx, Inc., has entered into a licensing agreement with IBM Research for use of its nanoscale sensors for accurate, rapid testing.
Read More